The global pharmaceutical packaging market size is expected to reach USD 153.93 billion by 2027, exhibit a CAGR of 6.4% during the forecast period. The growing adoption of novel and generic drugs in developing countries will have an excellent impact on the global market, states Fortune Business Insights, in a report, titled “Pharmaceutical Packaging Market Size, Share & COVID-19 Impact Analysis, By Material (Plastics, Glass, Metal, Paper & Paperboard,), By Product (Plastic Bottles, Caps & Closures, Pre-Fillable Inhalers, Pre-Fillable Syringes, Vials & Ampoules, Blister Packs, Bags & Pouches, Jars & Canisters, Cartridges,), By Packaging Type (Primary, Secondary, and Tertiary), By Drug Delivery Mode, and Regional Forecast, 2020-2027.”
The pharmaceutical packaging market size stood at USD 90.23 billion in 2019.
The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.
We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain this global pandemic.
The report on the pharmaceutical packaging market encompasses:
Grander analysis of the market
Important insights into the competitive landscape
Factors restricting market growth
Recent trends and development
Prime factors enabling growth
Booming Pharmaceutical Industry to Boost Market
The flourishing pharmaceutical industry in developing nations such as China, India, and Brazil and developed economies such as the US, UK, and Germany will spur lucrative opportunities for the market during the forecast period. The increasing technological advancements and healthcare spending will contribute positively to the market growth for pharmaceutical packaging. The growing healthcare awareness along with mandatory government regulations to curb the spread of infectious diseases will have a tremendous effect on the market. Moreover, the inflated demand for biological products and emerging treatments like cell and gene therapies will further enable the speedy expansion of the market.
Pharmaceutical Industry to Remain Unaffected During COVID-19 Pandemic
The coronavirus has disrupted various industries, resulting in the shortage of laborers&raw materials, distraught production processes, as well as transportation and logistics. However, the pharmaceutical industry remained unaffected owing to the government's support for the supply of essential drugs and goods. Pharmaceutical industries remained operational throughout the pandemic to manufacture healthcare products. The government backing for COVID kits and masks further encouraged packaging companies to accelerate their business amid the pandemic. The ongoing automated operations have increased sales in recent years, in turn, promotingthe growth of the market.
Heavy Demand for Packaging Products to Aid Expansion in North America
The market for pharmaceutical packaging in North America is expected to hold the largest share during the forecast period owing to the rapidly flourishing pharmaceutical industry. The increasing demand for packaging products will further enable speedy expansion in the region. The growing healthcare spending and rising prevalence of diseases will further spur demand in the region. The increasing utilization of pharmaceutical products such as plastic bottles & containers, vials & ampoules, and pre-fillable syringes will bolster the healthy growth of the market in North America. Asia Pacific is expected to hold a significant share in the global market owing to the growing pharmaceutical industry in countries such as China, Japan, and India. The rising investments by pharmaceutical manufacturing companies will contribute positively to the market growth.
June 2020: SCHOTT announced agreements with leading pharmaceutical companies, including partners of ‘Operation Warp Speed’ to deliver 2 billion doses of pharma vials packaging to COVID-19 vaccines
Request a sample PDF ( includes COVID-19 Impact Analysis):